Table 3

 Histological and immunohistochemical evaluation in spondyloarthropathy at baseline and week 12 in infliximab treated patients of study population I (n = 10)

Study population I (n = 10 infliximab)p Value
BaselineWeek 12
Semiquantitative histological and immunohistochemical scores are given as median (range). The immunohistochemical markers CD83 and CD1a (sublining layer) were scored as present (+) or absent (−). The p value was calculated for study population I using the paired Wilcoxon signed rank test for the semiquantitative scores and the McNemar test for the dichotomous scores.
NC, not calculable.
Lining layer
Synovial lining layer thickness1.5 (1 to 2)1 (1 to 1.5)0.015
αVβ3 lining0 (0 to 3)1 (0 to 2.5)0.516
VCAM-1 lining3 (1.5 to 3)1.5 (1 to 3)0.034
ICAM-1 lining3 (1.5 to 3)2.5 (1.5 to 3)0.238
E-selectin lining0 (0 to 1.5)0 (0 to 0.5)0.180
CD163 lining2 (0 to 2.5)1.5 (0 to 3)0.864
Blood vessels
Vascularity1.75 (1 to 3)1.25 (1 to 2.5)0.339
von Willebrand factor3 (0 to 3)1.5 (1 to 3)0.170
CD1463 (1 to 3)1.5 (0 to 3)0.105
αVβ3 endothelial1 (0 to 2.5)0 (0 to 1.5)0.058
VCAM-1 endothelial0 (0 to 1.5)0 (0 to 1.5)0.180
ICAM-1 endothelial3 (0 to 3)2.5 (1 to 3)1.000
E-selectin endothelial1.5 (0 to 3)1 (0 to 2.5)0.230
Sublining layer
VCAM-1 sublining1 (0 to 3)0 (0 to 2.5)0.173
ICAM-1 sublining3 (0 to 3)1.25 (0.5 to 3)0.141
E-selectin sublining2 (0.5 to 3)1 (0 to 2)0.034
Degree of inflammatory cell infiltration1.75 (0.5 to 2.5)0.75 (0 to 2)0.018
Number of neutrophils0.5 (0 to 3)0 (0 to 0)0.041
Number of lymphoid aggregates1.75 (0 to 3)0.5 (0 to 3)0.073
CD32 (0 to 3)0.5 (0 to 2)0.026
CD41.5 (0 to 3)0.5 (0 to 2)0.076
CD82 (0 to 2.5)1 (0 to 1)0.061
CD191 (0 to 3)0 (0 to 1)0.059
CD201.5 (0 to 3)1 (0 to 3)0.750
Number of plasma cells0.5 (0 to 3)0 (0 to 3)0.258
CD381.5 (0 to 3)1.5 (0 to 3)0.516
CD1381 (0 to 3)1 (0 to 3)0.680
CD682 (0 to 3)1 (0.5 to 2)0.034
CD1631.25 (0 to 3)0.5 (0 to 2.5)0.469
CD83 (+/−)4/90/9NC
CD1a (+/−)6/92/90.125